Loading...
XJPX
2540
Market cap304mUSD
Jul 29, Last price  
3,265.00JPY
1D
0.00%
1Q
6.35%
Jan 2017
73.86%
Name

Yomeishu Seizo Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
47.47
P/S
4.42
EPS
68.79
Div Yield, %
1.38%
Shrs. gr., 5y
0.14%
Rev. gr., 5y
-0.54%
Revenues
10.24b
-3.80%
13,556,466,00013,734,984,00012,323,501,00011,640,674,00011,589,021,00012,052,507,00012,968,246,00013,149,057,00012,703,583,00012,276,653,00010,655,361,00010,523,794,00010,478,935,00010,383,596,00010,577,246,00010,647,235,00010,242,250,000
Net income
953m
-6.64%
1,662,442,0001,728,776,0001,071,129,000705,928,000871,687,0001,242,808,0001,650,803,0001,857,263,0001,769,145,0001,368,822,0001,615,064,000686,793,000787,894,000807,559,000949,899,0001,020,603,000952,820,000
CFO
668m
-61.82%
1,886,985,0002,367,092,0001,822,644,0001,297,911,0001,950,423,0001,914,838,0001,974,230,0002,135,010,0001,140,024,0001,629,619,000759,705,0001,328,030,0001,363,185,0001,409,177,0001,806,702,0001,748,376,000667,517,000
Dividend
Mar 28, 20250 JPY/sh

Profile

Yomeishu Seizo Co., Ltd. produces and sells herbal liqueurs and pharmaceutical products in Japan, Hong Kong, Malaysia, Singapore, and Taiwan. It offers Yomeishu, an herbal liqueur; ginger, ginseng, honey, and medicinal liqueur; fruit and herbs liqueur; Kanomori and Kanoshizuku gin; and craft gin cocktail products. The company also provides Yomeishu cough drops; Yomeishu Seizo Amazake; Herb-no-Megumi; Ururu vinegar drinks; ginger black vinegar drinks; and dilution type black vinegar drinks. In addition, it offers Koken Seisai designated quasi-pharmaceutical and health products through the mail order site www.yomeishu-online.jp. Further, the company operates CLASUWA, a commercial complex; rents/leases real estate properties; manages restaurants and shops; and generates, supplies, and sells electricity through natural energy. Yomeishu Seizo Co., Ltd. was incorporated in 1923 and is headquartered in Tokyo, Japan.
IPO date
Oct 26, 1955
Employees
290
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
10,242,250
-3.80%
10,647,235
0.66%
Cost of revenue
9,546,482
9,655,330
Unusual Expense (Income)
NOPBT
695,768
991,905
NOPBT Margin
6.79%
9.32%
Operating Taxes
426,971
453,205
Tax Rate
61.37%
45.69%
NOPAT
268,797
538,700
Net income
952,820
-6.64%
1,020,603
7.44%
Dividends
(758,957)
(553,593)
Dividend yield
2.92%
2.15%
Proceeds from repurchase of equity
(266)
599,749
BB yield
0.00%
-2.33%
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
1,799,551
1,728,216
Net debt
(39,575,880)
(37,400,985)
Cash flow
Cash from operating activities
667,517
1,748,376
CAPEX
(2,492,000)
(386,624)
Cash from investing activities
2,313,757
(1,451,940)
Cash from financing activities
(760,146)
(554,767)
FCF
(2,457,993)
743,391
Balance
Cash
8,154,876
8,933,985
Long term investments
31,421,004
28,467,000
Excess cash
39,063,768
36,868,623
Stockholders' equity
2,688,407
47,304,099
Invested Capital
45,754,115
7,186,325
ROIC
1.02%
7.38%
ROCE
1.31%
2.11%
EV
Common stock shares outstanding
13,828
13,808
Price
1,881.00
0.70%
1,868.00
6.38%
Market cap
26,011,226
0.85%
25,792,929
6.55%
EV
(13,564,654)
(11,608,056)
EBITDA
1,263,349
1,505,006
EV/EBITDA
Interest
24,069
17,430
Interest/NOPBT
3.46%
1.76%